
Afadel 40mg Tablet
Marketer
Adley Formulations
Salt Composition
Afatinib dimaleate (40mg)
Overview Afadel 40mg Tablet
Oncaspart 40mg tablets treat non-small cell lung cancer in adults with specific epidermal growth factor receptor (EGFR) gene mutations. Administer this medication on an empty stomach, consistently at the same time daily for optimal efficacy. Dosage and frequency are determined by your physician based on your condition and may be adjusted. Strict adherence to your doctor's instructions is crucial; incorrect usage or overdosing can lead to severe adverse reactions. Therapeutic benefits may take weeks or months to manifest; discontinue only under medical guidance. Common side effects include nausea, rash, dry skin, and diarrhea (which may require medical attention and/or hydration). Regular blood tests may be recommended. Photosensitivity is possible; utilize sunscreen and protective clothing when exposed to sunlight. Report eye irritation (pain, redness, dryness) to your doctor. Prior to commencing treatment, disclose any respiratory, hepatic, or renal issues, or the use of infection-fighting medications. Inform your healthcare provider of all concurrent medications due to potential interactions. This medication is contraindicated during pregnancy and breastfeeding; reliable contraception is advised for women undergoing treatment.
Primary Ingredients of Afadel 40mg Tablet
No text provided. Please provide the text you wish me to rephrase.
Uses of Afadel 40mg Tablet
Lung cancer (excluding small cell type)
Major Benefits of Afadel 40mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the 40mg Afadel tablet whole; avoid chewing, crushing, or fracturing it. Administer on an empty stomach.
Common Side effects of Afadel 40mg Tablet:
- Diarrhea
- Rash
- Dry skin
- Nausea
- Vomiting
- Loss of appetite
- Itching
- Stomatitis (Inflammation of the mouth)
- Nail disorder
How to use Afadel 40mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the 40mg Afadel tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication on an empty stomach.
How Afadel 40mg Tablet works:
Afadel 40mg tablets are an anticancer drug that functions by attaching to and blocking key enzyme receptors (EGFR, HER2, and HER4) crucial for cancer cell proliferation. This action suppresses associated signaling pathways, thereby inhibiting or reducing cancer growth.
SAFETY ADVICE
AlcoholSAFE
There are no reported adverse reactions from combining Afadel 40mg Tablet with alcohol.
PregnancyCONSULT YOUR DOCTOR
Use of Afadel 40mg tablets is contraindicated during pregnancy due to established risk to the fetus. In exceptional circumstances involving life-threatening conditions, a physician might prescribe it if the potential benefits outweigh the risks. Always seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Use of the medication Afadel 40mg Tablet while breastfeeding is likely inadvisable. Preliminary human studies indicate potential transfer of the drug into breast milk, posing a possible risk to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Afadel 40mg Tablet on driving ability is unknown. Refrain from driving if you experience symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
Afadel 40mg tablets are likely safe for individuals with kidney impairment. Preliminary findings indicate dose modification may be unnecessary; however, physician consultation is recommended.
LiverSAFE IF PRESCRIBED
Afadel 40mg tablets are likely safe for individuals with liver conditions. Existing evidence indicates dose modification may be unnecessary, however, medical advice is recommended.
What if you forget to take Afadel 40mg Tablet :
Omit any missed Afadel 40mg Tablet dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Afadel 40mg Tablet
| Label | Value |
|---|---|
| Chemical Classification | Quinazoline-Butenamide Hybrid |
| Developing Good Habits | No. |
| Treatment Category | Cancer Medications |
| Action Class | Kinase inhibitors targeting tyrosine |
